8
|
Beaton DE, Terwee CB, Singh JA, Hawker GA, Patrick DL, Burke LB, Toupin-April K, Tugwell PS. A Call for Evidence-based Decision Making When Selecting Outcome Measurement Instruments for Summary of Findings Tables in Systematic Reviews: Results from an OMERACT Working Group. J Rheumatol 2015; 42:1954-1961. [PMID: 26373567 DOI: 10.3899/jrheum.141446] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
Abstract
OBJECTIVE Systematic reviews often struggle with how to combine information when more than 1 instrument is used across studies being synthesized. Different techniques have been suggested based on frequency of use in the literature, or on consensus. We explore an approach blending 2 initiatives: OMERACT (Outcome Measurement in Rheumatology) and COSMIN (Consensus On Selection of Measurement Instruments), and investigate the effects of an evidence-based measurement approach on selection of outcomes. METHODS Readings were circulated to attendees registered for a preconference workshop on pain measurement. Three instruments were considered and exercises conducted to engage people in the content and measurement performance of these tools. Consensus was sought that an evidence-based approach could be created for selection of instruments for summary of findings (SoF) tables. RESULTS The blending of COSMIN and OMERACT approaches led to an evidence-based approach that depended both on a clear definition of target concept and a review of measurement performance of the instrument. Participants emphasized that conceptual clarity and practical considerations should come before measurement property results. CONCLUSION Evidence-based approaches can be adopted for selection of instruments for SoF tables. A research agenda was formulated.
Collapse
Affiliation(s)
- Dorcas E Beaton
- From the Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto; Institute for Work & Health; University of Toronto, Toronto, Canada; VU University Medical Centre, Department of Epidemiology and Biostatistics and EMGO Institute for Health and Care Research, Amsterdam, The Netherlands; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, AL, USA; Women's College Hospital, Institute for Clinical Evaluative Sciences and University of Toronto, Toronto, Canada; Seattle Quality of Life Group\Center for Disability Policy and Research, University of Washington, Seattle, WA; Office of New Drugs, Centre for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA; Department of Epidemiology and Community Medicine, Faculty of Medicine, University of Ottawa; Department of Medicine, Faculty of Medicine, Ottawa Hospital Research Institute; Clinical Epidemiology Program, University of Ottawa; Department of Epidemiology and Community Medicine, Faculty of Medicine, Institute of Population Health, Ottawa, Canada. .,D.E. Beaton, BScOT, PhD, Senior Scientist Institute for Work & Health, Scientist St. Michael's Hospital; Associate Professor, University of Toronto; C.B. Terwee, PhD, Senior Epidemiologist, VU University Medical Centre, Department of Epidemiology and Biostatistics and EMGO Institute for Health and Care Research; J.A. Singh, MBBS, MPH, Associate Professor of Medicine, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; G.A. Hawker, MD, MSc, FRCPC, Women's College Hospital, Institute for Clinical Evaluative Sciences and University of Toronto; D.L. Patrick, PhD, Seattle Quality of Life Group\Center for Disability Policy and Research, University of Washington; L.B. Burke, RPh, MPH, Study Endpoints and Label Development, Office of New Drugs, Centre for Drug Evaluation and Research, Food and Drug Administration; K. Toupin-April, BScOT, PhD, Associate Scientist, Assistant Professor, Department of Epidemiology and Community Medicine, Faculty of Medicine, University of Ottawa; P.S. Tugwell, MD, MSc, University of Ottawa, Department of Medicine, Faculty of Medicine, Ottawa Hospital Research Institute, Clinical Epidemiology Program, University of Ottawa, Department of Epidemiology and Community Medicine, Faculty of Medicine, Institute of Population Health.
| | - Caroline B Terwee
- From the Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto; Institute for Work & Health; University of Toronto, Toronto, Canada; VU University Medical Centre, Department of Epidemiology and Biostatistics and EMGO Institute for Health and Care Research, Amsterdam, The Netherlands; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, AL, USA; Women's College Hospital, Institute for Clinical Evaluative Sciences and University of Toronto, Toronto, Canada; Seattle Quality of Life Group\Center for Disability Policy and Research, University of Washington, Seattle, WA; Office of New Drugs, Centre for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA; Department of Epidemiology and Community Medicine, Faculty of Medicine, University of Ottawa; Department of Medicine, Faculty of Medicine, Ottawa Hospital Research Institute; Clinical Epidemiology Program, University of Ottawa; Department of Epidemiology and Community Medicine, Faculty of Medicine, Institute of Population Health, Ottawa, Canada.,D.E. Beaton, BScOT, PhD, Senior Scientist Institute for Work & Health, Scientist St. Michael's Hospital; Associate Professor, University of Toronto; C.B. Terwee, PhD, Senior Epidemiologist, VU University Medical Centre, Department of Epidemiology and Biostatistics and EMGO Institute for Health and Care Research; J.A. Singh, MBBS, MPH, Associate Professor of Medicine, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; G.A. Hawker, MD, MSc, FRCPC, Women's College Hospital, Institute for Clinical Evaluative Sciences and University of Toronto; D.L. Patrick, PhD, Seattle Quality of Life Group\Center for Disability Policy and Research, University of Washington; L.B. Burke, RPh, MPH, Study Endpoints and Label Development, Office of New Drugs, Centre for Drug Evaluation and Research, Food and Drug Administration; K. Toupin-April, BScOT, PhD, Associate Scientist, Assistant Professor, Department of Epidemiology and Community Medicine, Faculty of Medicine, University of Ottawa; P.S. Tugwell, MD, MSc, University of Ottawa, Department of Medicine, Faculty of Medicine, Ottawa Hospital Research Institute, Clinical Epidemiology Program, University of Ottawa, Department of Epidemiology and Community Medicine, Faculty of Medicine, Institute of Population Health
| | - Jasvinder A Singh
- From the Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto; Institute for Work & Health; University of Toronto, Toronto, Canada; VU University Medical Centre, Department of Epidemiology and Biostatistics and EMGO Institute for Health and Care Research, Amsterdam, The Netherlands; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, AL, USA; Women's College Hospital, Institute for Clinical Evaluative Sciences and University of Toronto, Toronto, Canada; Seattle Quality of Life Group\Center for Disability Policy and Research, University of Washington, Seattle, WA; Office of New Drugs, Centre for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA; Department of Epidemiology and Community Medicine, Faculty of Medicine, University of Ottawa; Department of Medicine, Faculty of Medicine, Ottawa Hospital Research Institute; Clinical Epidemiology Program, University of Ottawa; Department of Epidemiology and Community Medicine, Faculty of Medicine, Institute of Population Health, Ottawa, Canada.,D.E. Beaton, BScOT, PhD, Senior Scientist Institute for Work & Health, Scientist St. Michael's Hospital; Associate Professor, University of Toronto; C.B. Terwee, PhD, Senior Epidemiologist, VU University Medical Centre, Department of Epidemiology and Biostatistics and EMGO Institute for Health and Care Research; J.A. Singh, MBBS, MPH, Associate Professor of Medicine, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; G.A. Hawker, MD, MSc, FRCPC, Women's College Hospital, Institute for Clinical Evaluative Sciences and University of Toronto; D.L. Patrick, PhD, Seattle Quality of Life Group\Center for Disability Policy and Research, University of Washington; L.B. Burke, RPh, MPH, Study Endpoints and Label Development, Office of New Drugs, Centre for Drug Evaluation and Research, Food and Drug Administration; K. Toupin-April, BScOT, PhD, Associate Scientist, Assistant Professor, Department of Epidemiology and Community Medicine, Faculty of Medicine, University of Ottawa; P.S. Tugwell, MD, MSc, University of Ottawa, Department of Medicine, Faculty of Medicine, Ottawa Hospital Research Institute, Clinical Epidemiology Program, University of Ottawa, Department of Epidemiology and Community Medicine, Faculty of Medicine, Institute of Population Health
| | - Gillian A Hawker
- From the Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto; Institute for Work & Health; University of Toronto, Toronto, Canada; VU University Medical Centre, Department of Epidemiology and Biostatistics and EMGO Institute for Health and Care Research, Amsterdam, The Netherlands; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, AL, USA; Women's College Hospital, Institute for Clinical Evaluative Sciences and University of Toronto, Toronto, Canada; Seattle Quality of Life Group\Center for Disability Policy and Research, University of Washington, Seattle, WA; Office of New Drugs, Centre for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA; Department of Epidemiology and Community Medicine, Faculty of Medicine, University of Ottawa; Department of Medicine, Faculty of Medicine, Ottawa Hospital Research Institute; Clinical Epidemiology Program, University of Ottawa; Department of Epidemiology and Community Medicine, Faculty of Medicine, Institute of Population Health, Ottawa, Canada.,D.E. Beaton, BScOT, PhD, Senior Scientist Institute for Work & Health, Scientist St. Michael's Hospital; Associate Professor, University of Toronto; C.B. Terwee, PhD, Senior Epidemiologist, VU University Medical Centre, Department of Epidemiology and Biostatistics and EMGO Institute for Health and Care Research; J.A. Singh, MBBS, MPH, Associate Professor of Medicine, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; G.A. Hawker, MD, MSc, FRCPC, Women's College Hospital, Institute for Clinical Evaluative Sciences and University of Toronto; D.L. Patrick, PhD, Seattle Quality of Life Group\Center for Disability Policy and Research, University of Washington; L.B. Burke, RPh, MPH, Study Endpoints and Label Development, Office of New Drugs, Centre for Drug Evaluation and Research, Food and Drug Administration; K. Toupin-April, BScOT, PhD, Associate Scientist, Assistant Professor, Department of Epidemiology and Community Medicine, Faculty of Medicine, University of Ottawa; P.S. Tugwell, MD, MSc, University of Ottawa, Department of Medicine, Faculty of Medicine, Ottawa Hospital Research Institute, Clinical Epidemiology Program, University of Ottawa, Department of Epidemiology and Community Medicine, Faculty of Medicine, Institute of Population Health
| | - Donald L Patrick
- From the Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto; Institute for Work & Health; University of Toronto, Toronto, Canada; VU University Medical Centre, Department of Epidemiology and Biostatistics and EMGO Institute for Health and Care Research, Amsterdam, The Netherlands; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, AL, USA; Women's College Hospital, Institute for Clinical Evaluative Sciences and University of Toronto, Toronto, Canada; Seattle Quality of Life Group\Center for Disability Policy and Research, University of Washington, Seattle, WA; Office of New Drugs, Centre for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA; Department of Epidemiology and Community Medicine, Faculty of Medicine, University of Ottawa; Department of Medicine, Faculty of Medicine, Ottawa Hospital Research Institute; Clinical Epidemiology Program, University of Ottawa; Department of Epidemiology and Community Medicine, Faculty of Medicine, Institute of Population Health, Ottawa, Canada.,D.E. Beaton, BScOT, PhD, Senior Scientist Institute for Work & Health, Scientist St. Michael's Hospital; Associate Professor, University of Toronto; C.B. Terwee, PhD, Senior Epidemiologist, VU University Medical Centre, Department of Epidemiology and Biostatistics and EMGO Institute for Health and Care Research; J.A. Singh, MBBS, MPH, Associate Professor of Medicine, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; G.A. Hawker, MD, MSc, FRCPC, Women's College Hospital, Institute for Clinical Evaluative Sciences and University of Toronto; D.L. Patrick, PhD, Seattle Quality of Life Group\Center for Disability Policy and Research, University of Washington; L.B. Burke, RPh, MPH, Study Endpoints and Label Development, Office of New Drugs, Centre for Drug Evaluation and Research, Food and Drug Administration; K. Toupin-April, BScOT, PhD, Associate Scientist, Assistant Professor, Department of Epidemiology and Community Medicine, Faculty of Medicine, University of Ottawa; P.S. Tugwell, MD, MSc, University of Ottawa, Department of Medicine, Faculty of Medicine, Ottawa Hospital Research Institute, Clinical Epidemiology Program, University of Ottawa, Department of Epidemiology and Community Medicine, Faculty of Medicine, Institute of Population Health
| | - Laurie B Burke
- From the Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto; Institute for Work & Health; University of Toronto, Toronto, Canada; VU University Medical Centre, Department of Epidemiology and Biostatistics and EMGO Institute for Health and Care Research, Amsterdam, The Netherlands; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, AL, USA; Women's College Hospital, Institute for Clinical Evaluative Sciences and University of Toronto, Toronto, Canada; Seattle Quality of Life Group\Center for Disability Policy and Research, University of Washington, Seattle, WA; Office of New Drugs, Centre for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA; Department of Epidemiology and Community Medicine, Faculty of Medicine, University of Ottawa; Department of Medicine, Faculty of Medicine, Ottawa Hospital Research Institute; Clinical Epidemiology Program, University of Ottawa; Department of Epidemiology and Community Medicine, Faculty of Medicine, Institute of Population Health, Ottawa, Canada.,D.E. Beaton, BScOT, PhD, Senior Scientist Institute for Work & Health, Scientist St. Michael's Hospital; Associate Professor, University of Toronto; C.B. Terwee, PhD, Senior Epidemiologist, VU University Medical Centre, Department of Epidemiology and Biostatistics and EMGO Institute for Health and Care Research; J.A. Singh, MBBS, MPH, Associate Professor of Medicine, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; G.A. Hawker, MD, MSc, FRCPC, Women's College Hospital, Institute for Clinical Evaluative Sciences and University of Toronto; D.L. Patrick, PhD, Seattle Quality of Life Group\Center for Disability Policy and Research, University of Washington; L.B. Burke, RPh, MPH, Study Endpoints and Label Development, Office of New Drugs, Centre for Drug Evaluation and Research, Food and Drug Administration; K. Toupin-April, BScOT, PhD, Associate Scientist, Assistant Professor, Department of Epidemiology and Community Medicine, Faculty of Medicine, University of Ottawa; P.S. Tugwell, MD, MSc, University of Ottawa, Department of Medicine, Faculty of Medicine, Ottawa Hospital Research Institute, Clinical Epidemiology Program, University of Ottawa, Department of Epidemiology and Community Medicine, Faculty of Medicine, Institute of Population Health
| | - Karine Toupin-April
- From the Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto; Institute for Work & Health; University of Toronto, Toronto, Canada; VU University Medical Centre, Department of Epidemiology and Biostatistics and EMGO Institute for Health and Care Research, Amsterdam, The Netherlands; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, AL, USA; Women's College Hospital, Institute for Clinical Evaluative Sciences and University of Toronto, Toronto, Canada; Seattle Quality of Life Group\Center for Disability Policy and Research, University of Washington, Seattle, WA; Office of New Drugs, Centre for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA; Department of Epidemiology and Community Medicine, Faculty of Medicine, University of Ottawa; Department of Medicine, Faculty of Medicine, Ottawa Hospital Research Institute; Clinical Epidemiology Program, University of Ottawa; Department of Epidemiology and Community Medicine, Faculty of Medicine, Institute of Population Health, Ottawa, Canada.,D.E. Beaton, BScOT, PhD, Senior Scientist Institute for Work & Health, Scientist St. Michael's Hospital; Associate Professor, University of Toronto; C.B. Terwee, PhD, Senior Epidemiologist, VU University Medical Centre, Department of Epidemiology and Biostatistics and EMGO Institute for Health and Care Research; J.A. Singh, MBBS, MPH, Associate Professor of Medicine, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; G.A. Hawker, MD, MSc, FRCPC, Women's College Hospital, Institute for Clinical Evaluative Sciences and University of Toronto; D.L. Patrick, PhD, Seattle Quality of Life Group\Center for Disability Policy and Research, University of Washington; L.B. Burke, RPh, MPH, Study Endpoints and Label Development, Office of New Drugs, Centre for Drug Evaluation and Research, Food and Drug Administration; K. Toupin-April, BScOT, PhD, Associate Scientist, Assistant Professor, Department of Epidemiology and Community Medicine, Faculty of Medicine, University of Ottawa; P.S. Tugwell, MD, MSc, University of Ottawa, Department of Medicine, Faculty of Medicine, Ottawa Hospital Research Institute, Clinical Epidemiology Program, University of Ottawa, Department of Epidemiology and Community Medicine, Faculty of Medicine, Institute of Population Health
| | - Peter S Tugwell
- From the Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto; Institute for Work & Health; University of Toronto, Toronto, Canada; VU University Medical Centre, Department of Epidemiology and Biostatistics and EMGO Institute for Health and Care Research, Amsterdam, The Netherlands; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, AL, USA; Women's College Hospital, Institute for Clinical Evaluative Sciences and University of Toronto, Toronto, Canada; Seattle Quality of Life Group\Center for Disability Policy and Research, University of Washington, Seattle, WA; Office of New Drugs, Centre for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA; Department of Epidemiology and Community Medicine, Faculty of Medicine, University of Ottawa; Department of Medicine, Faculty of Medicine, Ottawa Hospital Research Institute; Clinical Epidemiology Program, University of Ottawa; Department of Epidemiology and Community Medicine, Faculty of Medicine, Institute of Population Health, Ottawa, Canada.,D.E. Beaton, BScOT, PhD, Senior Scientist Institute for Work & Health, Scientist St. Michael's Hospital; Associate Professor, University of Toronto; C.B. Terwee, PhD, Senior Epidemiologist, VU University Medical Centre, Department of Epidemiology and Biostatistics and EMGO Institute for Health and Care Research; J.A. Singh, MBBS, MPH, Associate Professor of Medicine, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; G.A. Hawker, MD, MSc, FRCPC, Women's College Hospital, Institute for Clinical Evaluative Sciences and University of Toronto; D.L. Patrick, PhD, Seattle Quality of Life Group\Center for Disability Policy and Research, University of Washington; L.B. Burke, RPh, MPH, Study Endpoints and Label Development, Office of New Drugs, Centre for Drug Evaluation and Research, Food and Drug Administration; K. Toupin-April, BScOT, PhD, Associate Scientist, Assistant Professor, Department of Epidemiology and Community Medicine, Faculty of Medicine, University of Ottawa; P.S. Tugwell, MD, MSc, University of Ottawa, Department of Medicine, Faculty of Medicine, Ottawa Hospital Research Institute, Clinical Epidemiology Program, University of Ottawa, Department of Epidemiology and Community Medicine, Faculty of Medicine, Institute of Population Health
| |
Collapse
|
9
|
Beaton DE, Dyer S, Boonen A, Verstappen SMM, Escorpizo R, Lacaille DV, Bosworth A, Gignac MAM, Leong A, Purcaru O, Leggett S, Hofstetter C, Peterson IF, Tang K, Fautrel B, Bombardier C, Tugwell PS. OMERACT Filter Evidence Supporting the Measurement of At-work Productivity Loss as an Outcome Measure in Rheumatology Research. J Rheumatol 2015; 43:214-22. [PMID: 26329339 DOI: 10.3899/jrheum.141077] [Citation(s) in RCA: 32] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
OBJECTIVE Indicators of work role functioning (being at work, and being productive while at work) are important outcomes for persons with arthritis. As the worker productivity working group at OMERACT (Outcome Measures in Rheumatology), we sought to provide an evidence base for consensus on standardized instruments to measure worker productivity [both absenteeism and at-work productivity (presenteeism) as well as critical contextual factors]. METHODS Literature reviews and primary studies were done and reported to the OMERACT 12 (2014) meeting to build the OMERACT Filter 2.0 evidence for worker productivity outcome measurement instruments. Contextual factor domains that could have an effect on scores on worker productivity instruments were identified by nominal group techniques, and strength of influence was further assessed by literature review. RESULTS At OMERACT 9 (2008), we identified 6 candidate measures of absenteeism, which received 94% endorsement at the plenary vote. At OMERACT 11 (2012) we received over the required minimum vote of 70% for endorsement of 2 at-work productivity loss measures. During OMERACT 12 (2014), out of 4 measures of at-work productivity loss, 3 (1 global; 2 multiitem) received support as having passed the OMERACT Filter with over 70% of the plenary vote. In addition, 3 contextual factor domains received a 95% vote to explore their validity as core contextual factors: nature of work, work accommodation, and workplace support. CONCLUSION Our current recommendations for at-work productivity loss measures are: WALS (Workplace Activity Limitations Scale), WLQ PDmod (Work Limitations Questionnaire with modified physical demands scale), WAI (Work Ability Index), WPS (Arthritis-specific Work Productivity Survey), and WPAI (Work Productivity and Activity Impairment Questionnaire). Our future research focus will shift to confirming core contextual factors to consider in the measurement of worker productivity.
Collapse
Affiliation(s)
- Dorcas E Beaton
- From the Arthritis Research Centre of Canada, Vancouver, British Columbia, Canada; Arthritis Research UK Epidemiology Unit, University of Manchester; Manchester, UK; Bone and Joint Decade, the Global Alliance for Musculoskeletal Health, Santa Barbara, California, USA; Consumer Advisory Council, Canadian Arthritis Network, Canada; Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada; Department of Rehabilitation and Movement Science, The University of Vermont, Burlington, Vermont, USA; Department of Rheumatology, Pierre et Marie Curie University (UPMC - Paris 6), APHP Pitié-Salpétriêre Hospital, Paris, France; Department of Rheumatology, Skåne University Hospital, Malmo; Department of Orthopedics, Clinical Sciences, Lund University, Lund, Sweden; Division of Rheumatology, Maastricht University Medical Center, and CAPHRI Research Institute, Maastricht, the Netherlands; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia, Canada; Health Economics, GMAP, Immunology, UCB BioPharma SPRL, Brussells, Belgium; Institute for Work and Health; Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada; National Rheumatoid Arthritis Society, Maidenhead, Berkshire, UK; Toronto General Research Institute at the University Health Network, Toronto, Ontario, Canada.D. Lacaille holds the Mary Pack Chair in Arthritis Research from The Arthritis Society of Canada and the University of British Columbia. C. Bombardier holds a Canada Research Chair in Knowledge Transfer for Musculoskeletal Care and a Pfizer Chair in Rheumatology, University of Toronto, Faculty of Medicine's Rheumatology Division.D.E. Beaton, PhD, Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, and Institute for Work and Health, and Institute of Health Policy, Management and Evaluation, Rehabilitation Sciences Institute,
| | - Sarah Dyer
- From the Arthritis Research Centre of Canada, Vancouver, British Columbia, Canada; Arthritis Research UK Epidemiology Unit, University of Manchester; Manchester, UK; Bone and Joint Decade, the Global Alliance for Musculoskeletal Health, Santa Barbara, California, USA; Consumer Advisory Council, Canadian Arthritis Network, Canada; Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada; Department of Rehabilitation and Movement Science, The University of Vermont, Burlington, Vermont, USA; Department of Rheumatology, Pierre et Marie Curie University (UPMC - Paris 6), APHP Pitié-Salpétriêre Hospital, Paris, France; Department of Rheumatology, Skåne University Hospital, Malmo; Department of Orthopedics, Clinical Sciences, Lund University, Lund, Sweden; Division of Rheumatology, Maastricht University Medical Center, and CAPHRI Research Institute, Maastricht, the Netherlands; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia, Canada; Health Economics, GMAP, Immunology, UCB BioPharma SPRL, Brussells, Belgium; Institute for Work and Health; Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada; National Rheumatoid Arthritis Society, Maidenhead, Berkshire, UK; Toronto General Research Institute at the University Health Network, Toronto, Ontario, Canada.D. Lacaille holds the Mary Pack Chair in Arthritis Research from The Arthritis Society of Canada and the University of British Columbia. C. Bombardier holds a Canada Research Chair in Knowledge Transfer for Musculoskeletal Care and a Pfizer Chair in Rheumatology, University of Toronto, Faculty of Medicine's Rheumatology Division.D.E. Beaton, PhD, Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, and Institute for Work and Health, and Institute of Health Policy, Management and Evaluation, Rehabilitation Sciences Institute,
| | - Annelies Boonen
- From the Arthritis Research Centre of Canada, Vancouver, British Columbia, Canada; Arthritis Research UK Epidemiology Unit, University of Manchester; Manchester, UK; Bone and Joint Decade, the Global Alliance for Musculoskeletal Health, Santa Barbara, California, USA; Consumer Advisory Council, Canadian Arthritis Network, Canada; Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada; Department of Rehabilitation and Movement Science, The University of Vermont, Burlington, Vermont, USA; Department of Rheumatology, Pierre et Marie Curie University (UPMC - Paris 6), APHP Pitié-Salpétriêre Hospital, Paris, France; Department of Rheumatology, Skåne University Hospital, Malmo; Department of Orthopedics, Clinical Sciences, Lund University, Lund, Sweden; Division of Rheumatology, Maastricht University Medical Center, and CAPHRI Research Institute, Maastricht, the Netherlands; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia, Canada; Health Economics, GMAP, Immunology, UCB BioPharma SPRL, Brussells, Belgium; Institute for Work and Health; Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada; National Rheumatoid Arthritis Society, Maidenhead, Berkshire, UK; Toronto General Research Institute at the University Health Network, Toronto, Ontario, Canada.D. Lacaille holds the Mary Pack Chair in Arthritis Research from The Arthritis Society of Canada and the University of British Columbia. C. Bombardier holds a Canada Research Chair in Knowledge Transfer for Musculoskeletal Care and a Pfizer Chair in Rheumatology, University of Toronto, Faculty of Medicine's Rheumatology Division.D.E. Beaton, PhD, Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, and Institute for Work and Health, and Institute of Health Policy, Management and Evaluation, Rehabilitation Sciences Institute,
| | - Suzanne M M Verstappen
- From the Arthritis Research Centre of Canada, Vancouver, British Columbia, Canada; Arthritis Research UK Epidemiology Unit, University of Manchester; Manchester, UK; Bone and Joint Decade, the Global Alliance for Musculoskeletal Health, Santa Barbara, California, USA; Consumer Advisory Council, Canadian Arthritis Network, Canada; Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada; Department of Rehabilitation and Movement Science, The University of Vermont, Burlington, Vermont, USA; Department of Rheumatology, Pierre et Marie Curie University (UPMC - Paris 6), APHP Pitié-Salpétriêre Hospital, Paris, France; Department of Rheumatology, Skåne University Hospital, Malmo; Department of Orthopedics, Clinical Sciences, Lund University, Lund, Sweden; Division of Rheumatology, Maastricht University Medical Center, and CAPHRI Research Institute, Maastricht, the Netherlands; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia, Canada; Health Economics, GMAP, Immunology, UCB BioPharma SPRL, Brussells, Belgium; Institute for Work and Health; Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada; National Rheumatoid Arthritis Society, Maidenhead, Berkshire, UK; Toronto General Research Institute at the University Health Network, Toronto, Ontario, Canada.D. Lacaille holds the Mary Pack Chair in Arthritis Research from The Arthritis Society of Canada and the University of British Columbia. C. Bombardier holds a Canada Research Chair in Knowledge Transfer for Musculoskeletal Care and a Pfizer Chair in Rheumatology, University of Toronto, Faculty of Medicine's Rheumatology Division.D.E. Beaton, PhD, Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, and Institute for Work and Health, and Institute of Health Policy, Management and Evaluation, Rehabilitation Sciences Institute,
| | - Reuben Escorpizo
- From the Arthritis Research Centre of Canada, Vancouver, British Columbia, Canada; Arthritis Research UK Epidemiology Unit, University of Manchester; Manchester, UK; Bone and Joint Decade, the Global Alliance for Musculoskeletal Health, Santa Barbara, California, USA; Consumer Advisory Council, Canadian Arthritis Network, Canada; Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada; Department of Rehabilitation and Movement Science, The University of Vermont, Burlington, Vermont, USA; Department of Rheumatology, Pierre et Marie Curie University (UPMC - Paris 6), APHP Pitié-Salpétriêre Hospital, Paris, France; Department of Rheumatology, Skåne University Hospital, Malmo; Department of Orthopedics, Clinical Sciences, Lund University, Lund, Sweden; Division of Rheumatology, Maastricht University Medical Center, and CAPHRI Research Institute, Maastricht, the Netherlands; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia, Canada; Health Economics, GMAP, Immunology, UCB BioPharma SPRL, Brussells, Belgium; Institute for Work and Health; Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada; National Rheumatoid Arthritis Society, Maidenhead, Berkshire, UK; Toronto General Research Institute at the University Health Network, Toronto, Ontario, Canada.D. Lacaille holds the Mary Pack Chair in Arthritis Research from The Arthritis Society of Canada and the University of British Columbia. C. Bombardier holds a Canada Research Chair in Knowledge Transfer for Musculoskeletal Care and a Pfizer Chair in Rheumatology, University of Toronto, Faculty of Medicine's Rheumatology Division.D.E. Beaton, PhD, Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, and Institute for Work and Health, and Institute of Health Policy, Management and Evaluation, Rehabilitation Sciences Institute,
| | - Diane V Lacaille
- From the Arthritis Research Centre of Canada, Vancouver, British Columbia, Canada; Arthritis Research UK Epidemiology Unit, University of Manchester; Manchester, UK; Bone and Joint Decade, the Global Alliance for Musculoskeletal Health, Santa Barbara, California, USA; Consumer Advisory Council, Canadian Arthritis Network, Canada; Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada; Department of Rehabilitation and Movement Science, The University of Vermont, Burlington, Vermont, USA; Department of Rheumatology, Pierre et Marie Curie University (UPMC - Paris 6), APHP Pitié-Salpétriêre Hospital, Paris, France; Department of Rheumatology, Skåne University Hospital, Malmo; Department of Orthopedics, Clinical Sciences, Lund University, Lund, Sweden; Division of Rheumatology, Maastricht University Medical Center, and CAPHRI Research Institute, Maastricht, the Netherlands; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia, Canada; Health Economics, GMAP, Immunology, UCB BioPharma SPRL, Brussells, Belgium; Institute for Work and Health; Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada; National Rheumatoid Arthritis Society, Maidenhead, Berkshire, UK; Toronto General Research Institute at the University Health Network, Toronto, Ontario, Canada.D. Lacaille holds the Mary Pack Chair in Arthritis Research from The Arthritis Society of Canada and the University of British Columbia. C. Bombardier holds a Canada Research Chair in Knowledge Transfer for Musculoskeletal Care and a Pfizer Chair in Rheumatology, University of Toronto, Faculty of Medicine's Rheumatology Division.D.E. Beaton, PhD, Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, and Institute for Work and Health, and Institute of Health Policy, Management and Evaluation, Rehabilitation Sciences Institute,
| | - Ailsa Bosworth
- From the Arthritis Research Centre of Canada, Vancouver, British Columbia, Canada; Arthritis Research UK Epidemiology Unit, University of Manchester; Manchester, UK; Bone and Joint Decade, the Global Alliance for Musculoskeletal Health, Santa Barbara, California, USA; Consumer Advisory Council, Canadian Arthritis Network, Canada; Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada; Department of Rehabilitation and Movement Science, The University of Vermont, Burlington, Vermont, USA; Department of Rheumatology, Pierre et Marie Curie University (UPMC - Paris 6), APHP Pitié-Salpétriêre Hospital, Paris, France; Department of Rheumatology, Skåne University Hospital, Malmo; Department of Orthopedics, Clinical Sciences, Lund University, Lund, Sweden; Division of Rheumatology, Maastricht University Medical Center, and CAPHRI Research Institute, Maastricht, the Netherlands; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia, Canada; Health Economics, GMAP, Immunology, UCB BioPharma SPRL, Brussells, Belgium; Institute for Work and Health; Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada; National Rheumatoid Arthritis Society, Maidenhead, Berkshire, UK; Toronto General Research Institute at the University Health Network, Toronto, Ontario, Canada.D. Lacaille holds the Mary Pack Chair in Arthritis Research from The Arthritis Society of Canada and the University of British Columbia. C. Bombardier holds a Canada Research Chair in Knowledge Transfer for Musculoskeletal Care and a Pfizer Chair in Rheumatology, University of Toronto, Faculty of Medicine's Rheumatology Division.D.E. Beaton, PhD, Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, and Institute for Work and Health, and Institute of Health Policy, Management and Evaluation, Rehabilitation Sciences Institute,
| | - Monique A M Gignac
- From the Arthritis Research Centre of Canada, Vancouver, British Columbia, Canada; Arthritis Research UK Epidemiology Unit, University of Manchester; Manchester, UK; Bone and Joint Decade, the Global Alliance for Musculoskeletal Health, Santa Barbara, California, USA; Consumer Advisory Council, Canadian Arthritis Network, Canada; Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada; Department of Rehabilitation and Movement Science, The University of Vermont, Burlington, Vermont, USA; Department of Rheumatology, Pierre et Marie Curie University (UPMC - Paris 6), APHP Pitié-Salpétriêre Hospital, Paris, France; Department of Rheumatology, Skåne University Hospital, Malmo; Department of Orthopedics, Clinical Sciences, Lund University, Lund, Sweden; Division of Rheumatology, Maastricht University Medical Center, and CAPHRI Research Institute, Maastricht, the Netherlands; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia, Canada; Health Economics, GMAP, Immunology, UCB BioPharma SPRL, Brussells, Belgium; Institute for Work and Health; Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada; National Rheumatoid Arthritis Society, Maidenhead, Berkshire, UK; Toronto General Research Institute at the University Health Network, Toronto, Ontario, Canada.D. Lacaille holds the Mary Pack Chair in Arthritis Research from The Arthritis Society of Canada and the University of British Columbia. C. Bombardier holds a Canada Research Chair in Knowledge Transfer for Musculoskeletal Care and a Pfizer Chair in Rheumatology, University of Toronto, Faculty of Medicine's Rheumatology Division.D.E. Beaton, PhD, Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, and Institute for Work and Health, and Institute of Health Policy, Management and Evaluation, Rehabilitation Sciences Institute,
| | - Amye Leong
- From the Arthritis Research Centre of Canada, Vancouver, British Columbia, Canada; Arthritis Research UK Epidemiology Unit, University of Manchester; Manchester, UK; Bone and Joint Decade, the Global Alliance for Musculoskeletal Health, Santa Barbara, California, USA; Consumer Advisory Council, Canadian Arthritis Network, Canada; Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada; Department of Rehabilitation and Movement Science, The University of Vermont, Burlington, Vermont, USA; Department of Rheumatology, Pierre et Marie Curie University (UPMC - Paris 6), APHP Pitié-Salpétriêre Hospital, Paris, France; Department of Rheumatology, Skåne University Hospital, Malmo; Department of Orthopedics, Clinical Sciences, Lund University, Lund, Sweden; Division of Rheumatology, Maastricht University Medical Center, and CAPHRI Research Institute, Maastricht, the Netherlands; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia, Canada; Health Economics, GMAP, Immunology, UCB BioPharma SPRL, Brussells, Belgium; Institute for Work and Health; Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada; National Rheumatoid Arthritis Society, Maidenhead, Berkshire, UK; Toronto General Research Institute at the University Health Network, Toronto, Ontario, Canada.D. Lacaille holds the Mary Pack Chair in Arthritis Research from The Arthritis Society of Canada and the University of British Columbia. C. Bombardier holds a Canada Research Chair in Knowledge Transfer for Musculoskeletal Care and a Pfizer Chair in Rheumatology, University of Toronto, Faculty of Medicine's Rheumatology Division.D.E. Beaton, PhD, Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, and Institute for Work and Health, and Institute of Health Policy, Management and Evaluation, Rehabilitation Sciences Institute,
| | - Oana Purcaru
- From the Arthritis Research Centre of Canada, Vancouver, British Columbia, Canada; Arthritis Research UK Epidemiology Unit, University of Manchester; Manchester, UK; Bone and Joint Decade, the Global Alliance for Musculoskeletal Health, Santa Barbara, California, USA; Consumer Advisory Council, Canadian Arthritis Network, Canada; Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada; Department of Rehabilitation and Movement Science, The University of Vermont, Burlington, Vermont, USA; Department of Rheumatology, Pierre et Marie Curie University (UPMC - Paris 6), APHP Pitié-Salpétriêre Hospital, Paris, France; Department of Rheumatology, Skåne University Hospital, Malmo; Department of Orthopedics, Clinical Sciences, Lund University, Lund, Sweden; Division of Rheumatology, Maastricht University Medical Center, and CAPHRI Research Institute, Maastricht, the Netherlands; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia, Canada; Health Economics, GMAP, Immunology, UCB BioPharma SPRL, Brussells, Belgium; Institute for Work and Health; Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada; National Rheumatoid Arthritis Society, Maidenhead, Berkshire, UK; Toronto General Research Institute at the University Health Network, Toronto, Ontario, Canada.D. Lacaille holds the Mary Pack Chair in Arthritis Research from The Arthritis Society of Canada and the University of British Columbia. C. Bombardier holds a Canada Research Chair in Knowledge Transfer for Musculoskeletal Care and a Pfizer Chair in Rheumatology, University of Toronto, Faculty of Medicine's Rheumatology Division.D.E. Beaton, PhD, Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, and Institute for Work and Health, and Institute of Health Policy, Management and Evaluation, Rehabilitation Sciences Institute,
| | - Sarah Leggett
- From the Arthritis Research Centre of Canada, Vancouver, British Columbia, Canada; Arthritis Research UK Epidemiology Unit, University of Manchester; Manchester, UK; Bone and Joint Decade, the Global Alliance for Musculoskeletal Health, Santa Barbara, California, USA; Consumer Advisory Council, Canadian Arthritis Network, Canada; Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada; Department of Rehabilitation and Movement Science, The University of Vermont, Burlington, Vermont, USA; Department of Rheumatology, Pierre et Marie Curie University (UPMC - Paris 6), APHP Pitié-Salpétriêre Hospital, Paris, France; Department of Rheumatology, Skåne University Hospital, Malmo; Department of Orthopedics, Clinical Sciences, Lund University, Lund, Sweden; Division of Rheumatology, Maastricht University Medical Center, and CAPHRI Research Institute, Maastricht, the Netherlands; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia, Canada; Health Economics, GMAP, Immunology, UCB BioPharma SPRL, Brussells, Belgium; Institute for Work and Health; Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada; National Rheumatoid Arthritis Society, Maidenhead, Berkshire, UK; Toronto General Research Institute at the University Health Network, Toronto, Ontario, Canada.D. Lacaille holds the Mary Pack Chair in Arthritis Research from The Arthritis Society of Canada and the University of British Columbia. C. Bombardier holds a Canada Research Chair in Knowledge Transfer for Musculoskeletal Care and a Pfizer Chair in Rheumatology, University of Toronto, Faculty of Medicine's Rheumatology Division.D.E. Beaton, PhD, Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, and Institute for Work and Health, and Institute of Health Policy, Management and Evaluation, Rehabilitation Sciences Institute,
| | - Cathy Hofstetter
- From the Arthritis Research Centre of Canada, Vancouver, British Columbia, Canada; Arthritis Research UK Epidemiology Unit, University of Manchester; Manchester, UK; Bone and Joint Decade, the Global Alliance for Musculoskeletal Health, Santa Barbara, California, USA; Consumer Advisory Council, Canadian Arthritis Network, Canada; Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada; Department of Rehabilitation and Movement Science, The University of Vermont, Burlington, Vermont, USA; Department of Rheumatology, Pierre et Marie Curie University (UPMC - Paris 6), APHP Pitié-Salpétriêre Hospital, Paris, France; Department of Rheumatology, Skåne University Hospital, Malmo; Department of Orthopedics, Clinical Sciences, Lund University, Lund, Sweden; Division of Rheumatology, Maastricht University Medical Center, and CAPHRI Research Institute, Maastricht, the Netherlands; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia, Canada; Health Economics, GMAP, Immunology, UCB BioPharma SPRL, Brussells, Belgium; Institute for Work and Health; Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada; National Rheumatoid Arthritis Society, Maidenhead, Berkshire, UK; Toronto General Research Institute at the University Health Network, Toronto, Ontario, Canada.D. Lacaille holds the Mary Pack Chair in Arthritis Research from The Arthritis Society of Canada and the University of British Columbia. C. Bombardier holds a Canada Research Chair in Knowledge Transfer for Musculoskeletal Care and a Pfizer Chair in Rheumatology, University of Toronto, Faculty of Medicine's Rheumatology Division.D.E. Beaton, PhD, Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, and Institute for Work and Health, and Institute of Health Policy, Management and Evaluation, Rehabilitation Sciences Institute,
| | - Ingemar F Peterson
- From the Arthritis Research Centre of Canada, Vancouver, British Columbia, Canada; Arthritis Research UK Epidemiology Unit, University of Manchester; Manchester, UK; Bone and Joint Decade, the Global Alliance for Musculoskeletal Health, Santa Barbara, California, USA; Consumer Advisory Council, Canadian Arthritis Network, Canada; Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada; Department of Rehabilitation and Movement Science, The University of Vermont, Burlington, Vermont, USA; Department of Rheumatology, Pierre et Marie Curie University (UPMC - Paris 6), APHP Pitié-Salpétriêre Hospital, Paris, France; Department of Rheumatology, Skåne University Hospital, Malmo; Department of Orthopedics, Clinical Sciences, Lund University, Lund, Sweden; Division of Rheumatology, Maastricht University Medical Center, and CAPHRI Research Institute, Maastricht, the Netherlands; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia, Canada; Health Economics, GMAP, Immunology, UCB BioPharma SPRL, Brussells, Belgium; Institute for Work and Health; Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada; National Rheumatoid Arthritis Society, Maidenhead, Berkshire, UK; Toronto General Research Institute at the University Health Network, Toronto, Ontario, Canada.D. Lacaille holds the Mary Pack Chair in Arthritis Research from The Arthritis Society of Canada and the University of British Columbia. C. Bombardier holds a Canada Research Chair in Knowledge Transfer for Musculoskeletal Care and a Pfizer Chair in Rheumatology, University of Toronto, Faculty of Medicine's Rheumatology Division.D.E. Beaton, PhD, Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, and Institute for Work and Health, and Institute of Health Policy, Management and Evaluation, Rehabilitation Sciences Institute,
| | - Kenneth Tang
- From the Arthritis Research Centre of Canada, Vancouver, British Columbia, Canada; Arthritis Research UK Epidemiology Unit, University of Manchester; Manchester, UK; Bone and Joint Decade, the Global Alliance for Musculoskeletal Health, Santa Barbara, California, USA; Consumer Advisory Council, Canadian Arthritis Network, Canada; Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada; Department of Rehabilitation and Movement Science, The University of Vermont, Burlington, Vermont, USA; Department of Rheumatology, Pierre et Marie Curie University (UPMC - Paris 6), APHP Pitié-Salpétriêre Hospital, Paris, France; Department of Rheumatology, Skåne University Hospital, Malmo; Department of Orthopedics, Clinical Sciences, Lund University, Lund, Sweden; Division of Rheumatology, Maastricht University Medical Center, and CAPHRI Research Institute, Maastricht, the Netherlands; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia, Canada; Health Economics, GMAP, Immunology, UCB BioPharma SPRL, Brussells, Belgium; Institute for Work and Health; Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada; National Rheumatoid Arthritis Society, Maidenhead, Berkshire, UK; Toronto General Research Institute at the University Health Network, Toronto, Ontario, Canada.D. Lacaille holds the Mary Pack Chair in Arthritis Research from The Arthritis Society of Canada and the University of British Columbia. C. Bombardier holds a Canada Research Chair in Knowledge Transfer for Musculoskeletal Care and a Pfizer Chair in Rheumatology, University of Toronto, Faculty of Medicine's Rheumatology Division.D.E. Beaton, PhD, Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, and Institute for Work and Health, and Institute of Health Policy, Management and Evaluation, Rehabilitation Sciences Institute,
| | - Bruno Fautrel
- From the Arthritis Research Centre of Canada, Vancouver, British Columbia, Canada; Arthritis Research UK Epidemiology Unit, University of Manchester; Manchester, UK; Bone and Joint Decade, the Global Alliance for Musculoskeletal Health, Santa Barbara, California, USA; Consumer Advisory Council, Canadian Arthritis Network, Canada; Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada; Department of Rehabilitation and Movement Science, The University of Vermont, Burlington, Vermont, USA; Department of Rheumatology, Pierre et Marie Curie University (UPMC - Paris 6), APHP Pitié-Salpétriêre Hospital, Paris, France; Department of Rheumatology, Skåne University Hospital, Malmo; Department of Orthopedics, Clinical Sciences, Lund University, Lund, Sweden; Division of Rheumatology, Maastricht University Medical Center, and CAPHRI Research Institute, Maastricht, the Netherlands; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia, Canada; Health Economics, GMAP, Immunology, UCB BioPharma SPRL, Brussells, Belgium; Institute for Work and Health; Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada; National Rheumatoid Arthritis Society, Maidenhead, Berkshire, UK; Toronto General Research Institute at the University Health Network, Toronto, Ontario, Canada.D. Lacaille holds the Mary Pack Chair in Arthritis Research from The Arthritis Society of Canada and the University of British Columbia. C. Bombardier holds a Canada Research Chair in Knowledge Transfer for Musculoskeletal Care and a Pfizer Chair in Rheumatology, University of Toronto, Faculty of Medicine's Rheumatology Division.D.E. Beaton, PhD, Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, and Institute for Work and Health, and Institute of Health Policy, Management and Evaluation, Rehabilitation Sciences Institute,
| | - Claire Bombardier
- From the Arthritis Research Centre of Canada, Vancouver, British Columbia, Canada; Arthritis Research UK Epidemiology Unit, University of Manchester; Manchester, UK; Bone and Joint Decade, the Global Alliance for Musculoskeletal Health, Santa Barbara, California, USA; Consumer Advisory Council, Canadian Arthritis Network, Canada; Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada; Department of Rehabilitation and Movement Science, The University of Vermont, Burlington, Vermont, USA; Department of Rheumatology, Pierre et Marie Curie University (UPMC - Paris 6), APHP Pitié-Salpétriêre Hospital, Paris, France; Department of Rheumatology, Skåne University Hospital, Malmo; Department of Orthopedics, Clinical Sciences, Lund University, Lund, Sweden; Division of Rheumatology, Maastricht University Medical Center, and CAPHRI Research Institute, Maastricht, the Netherlands; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia, Canada; Health Economics, GMAP, Immunology, UCB BioPharma SPRL, Brussells, Belgium; Institute for Work and Health; Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada; National Rheumatoid Arthritis Society, Maidenhead, Berkshire, UK; Toronto General Research Institute at the University Health Network, Toronto, Ontario, Canada.D. Lacaille holds the Mary Pack Chair in Arthritis Research from The Arthritis Society of Canada and the University of British Columbia. C. Bombardier holds a Canada Research Chair in Knowledge Transfer for Musculoskeletal Care and a Pfizer Chair in Rheumatology, University of Toronto, Faculty of Medicine's Rheumatology Division.D.E. Beaton, PhD, Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, and Institute for Work and Health, and Institute of Health Policy, Management and Evaluation, Rehabilitation Sciences Institute,
| | - Peter S Tugwell
- From the Arthritis Research Centre of Canada, Vancouver, British Columbia, Canada; Arthritis Research UK Epidemiology Unit, University of Manchester; Manchester, UK; Bone and Joint Decade, the Global Alliance for Musculoskeletal Health, Santa Barbara, California, USA; Consumer Advisory Council, Canadian Arthritis Network, Canada; Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada; Department of Rehabilitation and Movement Science, The University of Vermont, Burlington, Vermont, USA; Department of Rheumatology, Pierre et Marie Curie University (UPMC - Paris 6), APHP Pitié-Salpétriêre Hospital, Paris, France; Department of Rheumatology, Skåne University Hospital, Malmo; Department of Orthopedics, Clinical Sciences, Lund University, Lund, Sweden; Division of Rheumatology, Maastricht University Medical Center, and CAPHRI Research Institute, Maastricht, the Netherlands; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia, Canada; Health Economics, GMAP, Immunology, UCB BioPharma SPRL, Brussells, Belgium; Institute for Work and Health; Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada; National Rheumatoid Arthritis Society, Maidenhead, Berkshire, UK; Toronto General Research Institute at the University Health Network, Toronto, Ontario, Canada.D. Lacaille holds the Mary Pack Chair in Arthritis Research from The Arthritis Society of Canada and the University of British Columbia. C. Bombardier holds a Canada Research Chair in Knowledge Transfer for Musculoskeletal Care and a Pfizer Chair in Rheumatology, University of Toronto, Faculty of Medicine's Rheumatology Division.D.E. Beaton, PhD, Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, and Institute for Work and Health, and Institute of Health Policy, Management and Evaluation, Rehabilitation Sciences Institute,
| |
Collapse
|